EcoDrugPlus

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSSPAG00000004953
Gene Symbol: LOC103375696
3 Cross references
128 Possible Orthologues:

Apelin Receptor A-Like

Ensembl ID : ENSSPAG00000022248
Gene Symbol: LOC103353251
3 Cross references
171 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSSPAG00000000458
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSSPAG00000014019
Gene Symbol: ALOX5
2 Cross references
223 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSSPAG00000011537
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSSPAG00000023174
Gene Symbol: LOC103362102
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSSPAG00000010641
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSPAG00000020513
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSPAG00000006182
Gene Symbol: AVPR2
4 Cross references
148 Possible Orthologues:

Aromatase

Ensembl ID : ENSSPAG00000008892
Gene Symbol: LOC103362920
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSSPAG00000005849
Gene Symbol: LOC103370100
3 Cross references
190 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSSPAG00000021494
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).